Hence, the authors proposed sCD163 as a diagnostic marker for NAFLD; however, it did not correlate with the NAFLD fibrosis score which prevented it to predict fibrosis severity. This evidence concerns the gene CD163 and metabolic dysfunction-associated steatotic liver disease.